MAPK3

From Wikipedia, the free encyclopedia


Mitogen-activated protein kinase 3
Identifiers
Symbol(s) MAPK3; ERK1; HS44KDAP; HUMKER1A; MGC20180; P44ERK1; P44MAPK; PRKM3
External IDs OMIM: 601795 MGI1346859 HomoloGene55682
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 5595 26417
Ensembl ENSG00000102882 ENSMUSG00000063065
Uniprot P27361 Q63844
Refseq NM_001040056 (mRNA)
NP_001035145 (protein)
NM_011952 (mRNA)
NP_036082 (protein)
Location Chr 16: 30.03 - 30.04 Mb Chr 7: 126.55 - 126.56 Mb
Pubmed search [1] [2]

Mitogen-activated protein kinase 3, also known as MAPK3, is a human gene.

The protein encoded by this gene is a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act in a signaling cascade that regulates various cellular processes such as proliferation, differentiation, and cell cycle progression in response to a variety of extracellular signals. This kinase is activated by upstream kinases, resulting in its translocation to the nucleus where it phosphorylates nuclear targets. Alternatively spliced transcript variants encoding different protein isoforms have been described.[1]

[edit] References

[edit] Further reading

  • Peruzzi F, Gordon J, Darbinian N, Amini S (2003). "Tat-induced deregulation of neuronal differentiation and survival by nerve growth factor pathway.". J. Neurovirol. 8 Suppl 2: 91–6. doi:10.1080/13550280290167885. PMID 12491158. 
  • Meloche S, Pouysségur J (2007). "The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition.". Oncogene 26 (22): 3227–39. doi:10.1038/sj.onc.1210414. PMID 17496918. 
  • Ruscica M, Dozio E, Motta M, Magni P (2007). "Modulatory actions of neuropeptide Y on prostate cancer growth: role of MAP kinase/ERK 1/2 activation.". Adv. Exp. Med. Biol. 604: 96–100. PMID 17695723.